MENU
REPL
AS OF
Nov 13, 04:59 PM (EDT)
Price
$8.98
Change
-$0.06 (-0.66%)
Capitalization
709.91M
90 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
REPL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Replimune Group (REPL) Earnings Date & Reports

Replimune Group Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

REPL is expected to report earnings to fall 25.79% to -66 cents per share on February 11

Replimune Group REPL Stock Earnings Reports
Q4'25
Est.
$-0.67
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.11
Q1'25
Missed
by $2.35
Q4'24
Missed
by $0.03
The last earnings report on November 06 showed earnings per share of -89 cents, missing the estimate of -77 cents. With 1.30M shares outstanding, the current market capitalization sits at 709.91M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
REPL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. REPL showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for REPL
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com